| Company Name: |
BOC Sciences
|
| Tel: |
|
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:BMS-986141
CAS:1478711-48-6
Package:$4998/100mg Remarks:BMS-986141 is a potential medication under the clinical trial that evaluates the pharmacokinetics of BMS-986141 in participants with hepatic impairment compared to healthy participants.
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:BMS-986141
CAS:1478711-48-6
Purity:99% Package:1mg;2mg;5mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:BMS-986141
CAS:1478711-48-6
Purity:99.11% Package:1mg/RMB 5780;5mg/RMB 11600;10mg/RMB 15600
|
|
| | Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl- Basic information |
| Product Name: | Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl- | | Synonyms: | Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl-;BMS-986141;4-(4-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzofuran-4-yl)oxy)methyl)thiazol-2-yl)-N,N-dimethylbenzamide | | CAS: | 1478711-48-6 | | MF: | C27H23N5O5S2 | | MW: | 561.63 | | EINECS: | | | Product Categories: | | | Mol File: | 1478711-48-6.mol | ![Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl- Structure](CAS/20210111/GIF/1478711-48-6.gif) |
| | Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl- Chemical Properties |
| density | 1.47±0.1 g/cm3(Predicted) | | form | Solid | | pka | 0.52±0.50(Predicted) | | color | White to off-white |
| | Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl- Usage And Synthesis |
| Uses | BMS-98614 is an orally active, selective thrombin receptor protease-activated receptor-4 (PAR-4) antagonist with an IC50 value of 0.4 nM. BMS-98614 has excellent antithrombotic effect[1][2]. | | in vivo | BMS-986141 (compound 49) shows a slight but significant prolongation of KBT (kidney bleeding time) and demonstrates excellent anti-thrombotic efficacy at 0.5 mg/kg in cynomolgus monkey[1][2].
| Animal Model: | Monkey arterial thrombosis (AT) and mesenteric bleeding time (MBT) models[2] | | Dosage: | 0.05, 0.1, 0.5 mg/kg | | Administration: | p.o., 2 hours | | Result: | Inhibited PAR4-AP-induced platelet aggregation in human and monkey blood with IC50 of 1.8 and 1.3 nM, respectively.
Reduced the thrombus weight by 36%, 63% and 88% at concentrations of 0.05, 0.1 and 0.5 mg/kg, respectively in AT model.
Increased MBT by 1.2 times.
|
| Animal Model: | Rat, dog and monkey[1] | | Dosage: | 0.5, 1, 2 mpk | | Administration: | i.v., 0.5 mpk, 10 min or p.o., 2 mpk for rat, 1 mpk for dog and monkey | | Result: | The pharmacokinetic parameters of BMS-986141 (compound 49)
| Parameters | rat | dog | monkey | | t1/2(h) | 3.7 ± 0.4 | 13 | 75 ± 12 | | CL (mL/min/kg) | 14.3 ± 0.4 | 8.5 | 12 ± 2 | | Vss(L/kg) | 2.7 ± 0.3 | 2.7 | 14 ± 5 | | F (%) | 31 | 25 | 36 | |
|
| | IC 50 | PAR4: .4 nM (IC50) | | References | [1] E Scott Priestley, et al. Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4. J Med Chem. 2022 Jul 14;65(13):8843-8854. DOI:10.1021/acs.jmedchem.2c00359
[2] P Wong, et al. Favorable therapeutic index of an orally-active small-molecule antagonist of the platelet protease-activated receptor-4, BMS-986141, compared with the P2Y12 antagonist ticagrelor in cynomolgus monkeys. European Heart Journal, Volume 41, Issue Supplement_2, November 2020. |
| | Benzamide, 4-[4-[[[6-methoxy-2-(2-methoxyimidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-4-benzofuranyl]oxy]methyl]-2-thiazolyl]-N,N-dimethyl- Preparation Products And Raw materials |
|